Brand name

Trulicity

Weekly dulaglutide injection for type 2 diabetes, with cardiovascular benefit proven in primary prevention.

Active ingredient: Dulaglutide
FDA-approved for: Type 2 diabetes (2014)
Manufacturer: Eli Lilly
Active ingredientDulaglutide
FDA-approved forType 2 diabetes (2014)
ManufacturerEli Lilly
How takenWeekly injection pen
Max dose4.5 mg / week
PrescriptionRequired — Rx only

What is Trulicity?

Trulicity is dulaglutide, a weekly GLP-1 injection approved in 2014 for type 2 diabetes. For most of the decade that followed it was the most prescribed GLP-1 in America, largely because its pen is the easiest of the class to use — no dose dial, no needle to attach, no priming.

It is a diabetes drug, not a weight loss drug. Weight does come down, but only about 7 to 10 lbs at the top dose — well short of what semaglutide and tirzepatide produce.

Its distinguishing clinical result is REWIND, the cardiovascular outcomes trial that included a majority of patients without established heart disease. That primary-prevention population is unusual and is why Trulicity carries a broader cardiovascular indication than most of the class.

How it works

Dulaglutide fuses a GLP-1 analogue to an antibody fragment. The antibody portion is large enough to slow renal clearance dramatically, which gives the drug a half-life of about five days and allows once-weekly dosing.

At the receptor the effects are the familiar ones: glucose-dependent insulin release, glucagon suppression, slower gastric emptying, and reduced appetite. The appetite effect is weaker than semaglutide’s, which is the main reason weight loss on Trulicity is modest.

Dosing schedule

Trulicity steps up every 4 weeks; 0.75 and 1.5 mg are the long-standing doses, with 3 and 4.5 mg added in 2020:

DoseWhen
0.75 mg / weekStarting dose
1.5 mg / weekStandard maintenance dose
3 mg / weekStep up after 4+ weeks if needed
4.5 mg / weekMaximum dose

Results in clinical trials

~1.1–1.9 point A1C reduction; 12% fewer major cardiovascular events

Across the AWARD program, dulaglutide lowered A1C by roughly 1.1 to 1.9 points depending on dose and comparator. In REWIND, it reduced major adverse cardiovascular events by 12% over a median 5.4 years — notable because about two-thirds of participants had no prior cardiovascular event. Average weight loss at 4.5 mg runs 7 to 10 lbs.

Side effects

Common

  • Nausea
  • Diarrhea
  • Vomiting
  • Abdominal pain
  • Decreased appetite
  • Indigestion
  • Fatigue

Serious (rare)

  • Pancreatitis
  • Gallbladder disease
  • Kidney injury from dehydration
  • Severe hypoglycemia with insulin or sulfonylureas
  • Hypersensitivity reactions
Boxed warning: Boxed warning for thyroid C-cell tumors seen in rodent studies. Contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.

How much does Trulicity cost?

Trulicity has no generic, but diabetes coverage is broad and Medicare protections now cap annual spend:

RouteTypical cost
List price~$990 / month
With insurance (diabetes diagnosis)$25–$100 / month copay
Lilly savings cardAs low as $25 / month (eligible commercial plans)
Medicare Part DCovered for diabetes; annual out-of-pocket capped under the IRA
Off-label for weight lossUsually full list price — not covered

Prices vary by clinic, dose, and location — always confirm directly. See real local pricing on our clinic listings.

Frequently asked questions

Does Trulicity cause weight loss?

Some, but not much — about 7 to 10 lbs at the 4.5 mg dose. It is approved for blood sugar, not weight. If weight loss is the goal, Wegovy or Zepbound are the on-label options and produce three to five times the result.

Trulicity vs Ozempic — which is better?

Ozempic generally produces a larger A1C drop and more weight loss. Trulicity’s advantages are the simpler pen, a broader cardiovascular indication from REWIND, and formulary position on some plans. Both are weekly injections.

Is there a generic for Trulicity?

No. Dulaglutide is a biologic, so it would need a biosimilar rather than a conventional generic, and none has been approved. Key patents run toward the end of the decade, with biosimilars not realistically expected until the 2030s.

Can I switch from Trulicity to Ozempic or Mounjaro?

Commonly done, and usually straightforward since all three are weekly. Your provider will restart at a low dose of the new drug rather than matching the old one milligram for milligram, because the doses are not equivalent across molecules.

Related medications

Guides

Primary sources

  1. Trulicity prescribing informationEli Lilly
  2. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND)The Lancet

This page is for educational purposes only and is not medical advice. Trulicity is a prescription medication — talk to a licensed healthcare provider about whether it is right for you. GLPFinders is a directory service and does not prescribe, sell, or dispense medications.

Find a Trulicity Provider Near You

Compare website-confirmed clinics offering GLP-1 treatment in your city, including disclosed pricing when available.

Browse Clinics →